Home Online Features Novo Nordisk expands patient access to authentic, FDA-approved Wegovy® via collaborations with multiple telehealth organizations
Novo Nordisk expands patient access to authentic, FDA-approved Wegovy® via collaborations with multiple telehealth organizations
Press Releases
April 29, 2025

Novo Nordisk expands patient access to authentic, FDA-approved Wegovy® via collaborations with multiple telehealth organizations

By Novo Nordisk Inc.

All doses of FDA-approved Wegovy®, the most widely prescribed and studied GLP-1 for weight loss, are now accessible to patients of select telehealth providers via simplified pathway to NovoCare® PharmacyProviders

bradford

The Bradford Era

email
Local & Social